Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1b, Randomized, Double-blind, Placebo-controlled Pilot Study to Evaluate the Effects of NMRA-323511 Among Healthy Elderly and Adults With Agitation Associated With Dementia Due to Alzheimer's Disease

NCT06546995 is registered in ClinicalTrials.gov with Neumora Therapeutics, Inc. as lead sponsor.

NCT NCT06546995
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06546995 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1b, Randomized, Double-blind, Placebo-controlled Pilot Study to Evaluate the Effects of NMRA-323511 Among Healthy Elderly and Adults With Agitation Associated With Dementia Due to Alzheimer's Disease
Lead sponsor
Neumora Therapeutics, Inc.
Phase
Phase 1
Overall status
Completed
Start date
July 9, 2024
Completion date
November 19, 2025
Enrollment
87 (actual)
Sites
26

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer's disease, healthy elderly